Accurate topological comparison of two recombinant human growth hormones by optical surface plasmon resonance.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 9177724)

Published in Anal Biochem on May 15, 1997

Authors

J C Mani1, J M Bras, C Agut, B Pau, N Vita, P Ferrara, A Bayol

Author Affiliations

1: CNRS UMR9921, Faculté de Pharmacie, Immunoanalyse et Innovation en Biologie clinique, Montpellier, France.

Articles by these authors

Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell (1997) 7.27

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature (1995) 6.72

In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem (1992) 6.44

Intramolecular masking of nuclear import signal on NF-AT4 by casein kinase I and MEKK1. Cell (1998) 2.57

Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med (1994) 2.29

A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1. Br J Haematol (1996) 2.21

Reliability and feasibility of pregnancy home-use tests: laboratory validation and diagnostic evaluation by 638 volunteers. Clin Chem (1993) 2.17

The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor. J Biol Chem (1998) 1.84

Structure of the metJBLF cluster in Escherichia coli K12. Sequence of the metB structural gene and of the 5'- and 3'-flanking regions of the metBL operon. J Biol Chem (1983) 1.77

Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett (1993) 1.62

Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett (1997) 1.57

Human lamin B receptor exhibits sterol C14-reductase activity in Saccharomyces cerevisiae. Biochim Biophys Acta (1998) 1.55

An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem (1995) 1.54

Nucleotide sequence of metF, the E. coli structural gene for 5-10 methylene tetrahydrofolate reductase and of its control region. Nucleic Acids Res (1983) 1.53

Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol (1994) 1.52

Morphologic techniques for the study of brown adipose tissue and white adipose tissue. Methods Mol Biol (2001) 1.51

Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett (1993) 1.48

Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14. J Exp Med (2000) 1.48

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer. Cancer Res (1989) 1.48

Human 76p: A new member of the gamma-tubulin-associated protein family. J Cell Biol (1999) 1.44

Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem (1996) 1.43

Receptors and transduction pathways for monocyte chemotactic protein-2 and monocyte chemotactic protein-3. Similarities and differences with MCP-1. J Immunol (1994) 1.42

Interleukin 13 is a B cell stimulating factor. J Exp Med (1994) 1.41

Nucleotide sequence of the metL gene of Escherichia coli. Its product, the bifunctional aspartokinase ii-homoserine dehydrogenase II, and the bifunctional product of the thrA gene, aspartokinase I-homoserine dehydrogenase I, derive from a common ancestor. J Biol Chem (1983) 1.39

Biological activity of chitosan: ultrastructural study. Biomaterials (1988) 1.39

The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol (1994) 1.36

Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells. Nature (1981) 1.35

Circulating cardiac troponin I in severe congestive heart failure. Circulation (1997) 1.32

Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett (1996) 1.32

Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol (1999) 1.32

High affinity RGD-binding sites at the plasma membrane of Arabidopsis thaliana links the cell wall. Plant J (1998) 1.30

The immunosuppressant SR 31747 blocks cell proliferation by inhibiting a steroid isomerase in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.30

Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol (1996) 1.28

Cloning and sequencing of PYBP, a pyrimidine-rich specific single strand DNA-binding protein. Nucleic Acids Res (1991) 1.27

Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem (1996) 1.26

beta-Endorphin: characteristics of binding sites in the rat brain. Biochem Biophys Res Commun (1979) 1.26

Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim Biophys Acta (1996) 1.23

An experimentally induced phlegmonous abscess by a strain of Bacteroides gingivalis in guinea pigs and mice. Antonie Van Leeuwenhoek (1981) 1.20

The related cytokines interleukin-13 and interleukin-4 are distinguished by differential production and differential effects on T lymphocytes. Eur Cytokine Netw (1997) 1.20

Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood (1994) 1.19

Whole blood capcellia CD4/CD8 immunoassay for enumeration of CD4+ and CD8+ peripheral T lymphocytes. Clin Chem (1999) 1.19

Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol (1994) 1.18

Cloning and expression in Escherichia coli of the gene encoding Aspergillus flavus urate oxidase. J Biol Chem (1992) 1.17

Interleukin-13 induces the production of interleukin-1 receptor antagonist (IL-1ra) and the expression of the mRNA for the intracellular (keratinocyte) form of IL-1ra in human myelomonocytic cells. Blood (1994) 1.17

Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14. Eur J Immunol (1993) 1.15

Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Mol Endocrinol (1988) 1.15

Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol (1996) 1.15

Purification and characterization of the human SR 31747A-binding protein. A nuclear membrane protein related to yeast sterol isomerase. J Biol Chem (1997) 1.13

Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group. Diabetes Metab (1997) 1.12

Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J Pharmacol Exp Ther (1997) 1.12

Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity. Immunol Rev (1982) 1.11

Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro. J Exp Med (1993) 1.11

Microparticle-enhanced nephelometric immunoassay for human C-reactive protein. J Clin Lab Anal (1992) 1.09

Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem (1996) 1.09

Characterization of two cloned human CB1 cannabinoid receptor isoforms. J Pharmacol Exp Ther (1996) 1.08

Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol (2000) 1.08

Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood (1995) 1.08

Comparison of human bronchial muscle responses to histamine in vivo with histamine and isoproterenol agonists in vitro. Am Rev Respir Dis (1986) 1.07

Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sci (1999) 1.07

Purification to homogeneity and NH2-terminal amino acid sequence of a novel interleukin 1 species derived from a human B cell line. J Immunol (1986) 1.07

Left ventricular systolic performance during upright bicycle exercise in patients with essential hypertension. Am J Med (1983) 1.06

Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur Cytokine Netw (1993) 1.05

Evidence for nerve growth factor-potentiating activities of the nonpeptidic compound SR 57746A in PC12 cells. J Neurochem (1995) 1.04

Characterization and comparison of the interleukin 13 receptor with the interleukin 4 receptor on several cell types. J Biol Chem (1995) 1.04

Identification of proteins of the yeast protein map using genetically manipulated strains and peptide-mass fingerprinting. Yeast (1996) 1.03

Construction and physical mapping of plasmids containing the metJBLF gene cluster of E. coli K12. Mol Gen Genet (1982) 1.03

Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in culture. Cornea (1997) 1.02

An Italian epidemiological multicentre study of nocturnal enuresis. Br J Urol (1998) 1.01

AD2, a phosphorylation-dependent monoclonal antibody directed against tau proteins found in Alzheimer's disease. Brain Res Mol Brain Res (1996) 1.00

Topological analysis of the peripheral benzodiazepine receptor in yeast mitochondrial membranes supports a five-transmembrane structure. J Biol Chem (1998) 1.00

Histamine contraction of isolated human airway muscle preparations: role of prostaglandins. J Pharmacol Exp Ther (1986) 1.00

Diazepam binding inhibitor is a paracrine/autocrine regulator of Leydig cell proliferation and steroidogenesis: action via peripheral-type benzodiazepine receptor and independent mechanisms. Endocrinology (1993) 0.99

Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies. Mol Immunol (1991) 0.99

Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur J Pharmacol (2000) 0.98

Monoclonal antibodies to low density lipoprotein used for the study of low- and very-low-density lipoproteins, in "ELISA" and immunoprecipitation technics. Biochem Biophys Res Commun (1984) 0.97

Autoimmunity to human thyroglobulin. Respective epitopic specificity patterns of anti-human thyroglobulin autoantibodies in patients with Sjögren's syndrome and patients with Hashimoto's thyroiditis. Arthritis Rheum (1991) 0.97

An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan. Res Immunol (1990) 0.97

Levels of ventricular myosin fragments in human sera after myocardial infarction, determined with monoclonal antibodies to myosin heavy chains. Eur J Clin Invest (1985) 0.97

Characterization of monoclonal antibodies to the estrogen-regulated Mr 52,000 glycoprotein and their use in MCF7 cells. Cancer Res (1985) 0.96

The purification of a high-molecular-weight, enzymatically inactive renin precursor from human kidney. J Hypertens (1984) 0.96

Self-organized neural maps of human protein sequences. Protein Sci (1994) 0.95

Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Eur J Pharmacol (1998) 0.95

Juxtacortical osteogenic sarcoma of the jaws. Review of the literature and report of a case. Oral Surg Oral Med Oral Pathol (1980) 0.95

Mutational analysis and molecular modelling of the antagonist SR 144528 binding site on the human cannabinoid CB(2) receptor. Eur J Pharmacol (2000) 0.95

Systematic exploration of the antigen binding activity of synthetic peptides isolated from the variable regions of immunoglobulins. J Biol Chem (1997) 0.95

CD14 is expressed and functional in human B cells. Eur J Immunol (1994) 0.95

Protocadherin 15 (PCDH15): a new secreted isoform and a potential marker for NK/T cell lymphomas. Oncogene (2006) 0.95

The Mr 18,000 subunit of the peripheral-type benzodiazepine receptor exhibits both benzodiazepine and isoquinoline carboxamide binding sites in the absence of the voltage-dependent anion channel or of the adenine nucleotide carrier. J Biol Chem (1997) 0.94